Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):336-7. doi: 10.1016/j.jaip.2015.09.019. Epub 2015 Nov 7.

Abstract

Episodic angioedema and eosinophilia (Gleich syndrome) has been distinguished from other hypereosinophilic syndromes by the absence of cardiac involvement. Here we report a case in which eosinophilic endomyocardial disease developed in a patient with episodic angioedema and eosinophilia.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Angioedema / immunology
  • Angioedema / surgery
  • Angioedema / therapy*
  • Child
  • Endomyocardial Fibrosis / immunology
  • Endomyocardial Fibrosis / surgery
  • Endomyocardial Fibrosis / therapy*
  • Eosine Yellowish-(YS) / analogs & derivatives*
  • Eosinophilia / immunology
  • Eosinophilia / surgery
  • Eosinophilia / therapy*
  • Female
  • Heart Valve Prosthesis Implantation
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Middle Aged
  • Mitral Valve Annuloplasty*
  • Mitral Valve Prolapse / immunology
  • Mitral Valve Prolapse / surgery
  • Mitral Valve Prolapse / therapy*
  • Recombinant Proteins / therapeutic use
  • Thapsigargin / analogs & derivatives*
  • Thapsigargin / immunology
  • Young Adult

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • eosinthapsigargin
  • Thapsigargin
  • Eosine Yellowish-(YS)